Stromedix Inc., of Cambridge, Mass., received U.S. Patent No...VIA Pharmaceuticals Inc., of San Francisco, received U.S. Patent No...Viralytics Ltd., of Sydney, Australia, was granted U.S. Patent No

AdnaGen AG, of Langenhagen, Germany, received U.S. Patent No...InterMune Inc., of Brisbane, Calif., received U.S. Patent No...Phylonix Pharmaceuticals, of Baltimore, received U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No...Orexigen Therapeutics Inc., of San Diego, was issued its "Weber/Cowley methods patent" (U.S. Patent No. 7,462,626), which covers methods of treating obesity with combinations of bupropion and naltrexone, the two active agents in Orexigen's lead drug, Contrave...Vical Inc., of San Diego, was issued U.S. Patent No

BioSante Pharmaceuticals Inc., of Lincolnshire, Ill., said its licensor Antares Pharma Inc., of Ewing, N.J., was issued U.S. Patent No...GeneNews Ltd., of Toronto, was granted U.S. Patent No

Epitomics Inc., of Burlingame, Calif., received U.S. Patent No...Gemin X, of Malvern, Pa., received U.S. Patent No...Novocell Inc., of San Diego, received U.S. Patent Nos

Adeona Pharmaceuticals Inc., of Ann Arbor, Mich., received U.S. Patent No...Arriva Pharmaceuticals, of Alameda, Calif., was granted U.S. Patent No...Compellis Pharmaceuticals, of Boston, was issued U.S. Patent No

Formatech Inc., of Andover, Mass., was issued U.S. Patent No...Geron Corp., of Menlo Park, Calif., received U.S. Patent No...Helix BioMedix Inc., of Bothell, Wash., received U.S. Patent No

Alexion Pharmaceuticals Inc., of Cheshire, Conn., was granted U.S. Patent No...Banyan Biomarkers Inc., of Alachua, Fla., was granted U.S. Patent No

The patent protects the company's rights to manufacture the Celution System in the U.S...EntreMed Inc., of Rockville, Md., received U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No...Oncothyreon Inc., of Bellevue, Wash., received U.S. Patent No...Vermillion Inc., of Fremont, Calif., received U.S. Patent No

Genta Inc., of Berkeley Heights, N.J., was issued U.S. Patent No...Idera Pharmaceuticals Inc., of Cambridge, Mass., received U.S. Patent Nos...Jivan Biologics Inc., of Berkeley, Calif., was awarded U.S. Patent No

Bioheart Inc., of Sunrise, Fla., was awarded U.S. Patent No...Biosearch Technologies Inc., of Novato, Calif., received U.S. Patent No...Elixir Pharmaceuticals Inc., of Cambridge, Mass., received U.S. Patent No

Theratechnologies Inc., of Montreal, received U.S. Patent No...Vermillion Inc., of Fremont, Calif., received U.S. Patent No...Xencor Inc., of Monrovia, Calif., received U.S. Patent No

Morphotek Inc., of Exton, Pa., received U.S. Patent No...RE39,816 (a reissue of U.S. Patent No. 6,461,828, titled "Conjunctive Analysis of Biological Marker Expression For Predicting Cardiac Mortality.") It relates to the combined use of a cardiac marker of cell injury with a marker of organ adaptation for prognosis of chronic congestive heart failure...Proteologics Inc., of Rehovot, Israel, received U.S. Patent No

Avicena Group Inc., of Palo Alto, Calif., received U.S. Patent No...CellCyte Genetics Corp., of Kirkland, Wash., received U.S. Patent No

Nventa Biopharmaceuticals Corp., of San Diego, was issued U.S. Patent No...Penwest Pharmaceuticals Co., of Danbury, Conn., received U.S. Patent No...Protox Therapeutics Inc., of Vancouver, British Columbia, received U.S. Patent No

Epigenomics AG, of Berlin, was issued U.S. Patent No...Idera Pharmaceuticals Inc., of Cambridge, Mass., was issued U.S. Patent No...Nanogen Inc., of San Diego, was granted U.S. Patent No

Javelin Pharmaceuticals Inc., of Cambridge, Mass., was granted U.S. Patent No...MorphoSys AG, of Martinsried, Germany, was granted U.S. Patent No...Urigen Pharmaceuticals Inc., of Burlingame, Calif., received U.S. Patent No

Arius Research Inc., of Toronto, was granted U.S. Patent No...Inc., of Bothell, Wash., was issued U.S. Patent No...Targeted Genetics Corp., of Seattle received U.S. Patent No